We are glad to announce that we got funded by the DZHK for conducting our first clinical trial in adult patients starting in 2022.

We are very happy to be nominated #ScienceBreakthrough of the year by the Falling Walls Foundation award!

In 2019 Spark helped kick-start the bioresorbable stent solution to make the GrOwnValve innovation a possible treatment for small (growing) patients.

In july 2018 the GrOwnValve Project Team won the BPW Canvas business plan price by the IBB Berlin.

We are very proud to have been able to be part of the research consortium that was able to reach a Sciencemag publication.

In Autumn of 2017 the GrOwnValve Project was rewarded the EXIST translational grant to bring the innovative technology into preclinical testing.

Our co-founder Jasper Emeis was interviewed about the win of the EIC by the Healthcapital online-magazin.

GrOwnValve wins the INAM Innovation Challenge 2021.

From August 2021 the EXIST II funding programme supported GrOwnValve for one year to establish Quality and Risk Management.

In November 2021, our project „Kleine Patienten – großer Bedarf“, administered by VDI, received funding by the German Federal Ministery of Education and Research.

Since April 2022, the EIC Accelerator Programme has helped with the transition of our products from research objects to their clinical application.

We are proud and happy to announce that our first clinical trial in (young) adult patients, starting in 2023, has received funding by the DZHK.

German nationwide broadcaster ZDF published a documentary on the topic of cardiac health, featuring GrOwnValve as an example of cutting edge RnD (from 37:00 onwards).